YaoGeJu

Company directoryChina company filings

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Shanghai Xudong Haipu Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 31 active records with this name as holder; 22 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

38 acceptance records as first applicant, grouped into 23 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Gadopentetic Acid Dimeglumine Salt Injection 1 records · Latest accepted 2026/08/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601560Supplement2026/08/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Fluorouracil Injection 3 records · Latest accepted 2026/07/16

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601362Supplement2026/07/16Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2151094Supplement2021/12/16Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2150651Supplement2021/06/08Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Esomeprazole Sodium for Injection 1 records · Latest accepted 2025/06/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501211Supplement2025/06/14Shanghai Xudong Haipu Pharmaceutical Co., Ltd.; Shanghai Fu Dan Fu Hua Pharma Co., Ltd. romanizedCDE ↗
硫酸特布他林雾化吸入用溶液 · No verified English name 1 records · Latest accepted 2025/05/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501938Generic2025/05/30Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Diazepam Injection 1 records · Latest accepted 2025/04/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550170Supplement2025/04/11Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Iohexol Injection 3 records · Latest accepted 2025/01/17

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550061Supplement2025/01/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.; Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanizedCDE ↗
CYHB2550060Supplement2025/01/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.; Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanizedCDE ↗
CYHB2550059Supplement2025/01/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.; Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanizedCDE ↗
Dobutamine Hydrochloride Injection 3 records · Latest accepted 2024/12/31

Supplement · 1Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402255Supplement2024/12/31Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2102338Generic2021/12/31Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2102337Generic2021/12/31Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Amiodarone Hydrochloride Injection 3 records · Latest accepted 2024/11/13

Supplement · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401882Supplement2024/11/13Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2401880Supplement2024/11/13Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2100105Generic2021/01/27Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Sodium Ibandronate Injection 3 records · Latest accepted 2024/06/21

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401865Generic2024/06/21Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2401864Generic2024/06/21Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2401863Generic2024/06/21Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Dexrazoxane for Injection 1 records · Latest accepted 2024/06/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401772Generic2024/06/12Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Phentolamine Mesilate Injection 1 records · Latest accepted 2024/04/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450246Supplement2024/04/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Flumazenil Injection 2 records · Latest accepted 2023/11/24

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303241Generic2023/11/24Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2303240Generic2023/11/24Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Magnesium Sulfate Injection 2 records · Latest accepted 2023/11/09

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350821Supplement2023/11/09Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2350820Supplement2023/11/09Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
氢溴酸加兰他敏注射液 · No verified English name 3 records · Latest accepted 2023/10/28

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302376Supplement2023/10/28Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2300514Supplement2023/03/10Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHB2102447Supplement2021/12/27Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Neostigmine Methylsulfate Injection 2 records · Latest accepted 2023/09/25

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302585Generic2023/09/25Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
CYHS2302584Generic2023/09/25Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Nicorandil for Injection 1 records · Latest accepted 2023/07/05

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301804Generic2023/07/05Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Macitentan Tablets 1 records · Latest accepted 2023/01/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2202176Generic2023/01/01Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Pentoxifylline Injection 1 records · Latest accepted 2022/09/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201620Generic2022/09/27Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Levosimendan Injection 1 records · Latest accepted 2022/01/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200110Generic2022/01/18Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Tramadol Hydrochloride Injection 1 records · Latest accepted 2021/12/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2151123Supplement2021/12/29Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Digoxin Injection 1 records · Latest accepted 2021/07/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101427Generic2021/07/15Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Warfarin Sodium Tablets 1 records · Latest accepted 2021/06/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101348Generic2021/06/25Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Succinylcholine Chloride Injection 1 records · Latest accepted 2021/01/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150033Supplement2021/01/15Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

5 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 applicationNo longer listed under review: 1 applicationNotification delivery: 3 applications

  1. 2026/11/18Marketing application approved

    硫酸特布他林吸入溶液 · No verified English name

    CYHS2501938 · 国药准字H20266605

    Fact date: 2026/11/18 · Publication date: 2026/11/19 · Date added to this site: 2026/11/19

    View source · Table row 53 ↗
  2. 2026/10/31No longer listed under review

    硫酸特布他林雾化吸入用溶液 · No verified English name

    CYHS2501938

    Fact date: 2026/10/31 · Date added to this site: 2026/10/31

    Accepted: 2025/05/30

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  3. 2026/10/28Notification delivery

    Sodium Ibandronate Injection

    CYHS2401865

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 7 ↗
  4. 2026/10/28Notification delivery

    Sodium Ibandronate Injection

    CYHS2401864

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 6 ↗
  5. 2026/10/28Notification delivery

    Sodium Ibandronate Injection

    CYHS2401863

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 5 ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Gadopentetic Acid Dimeglumine Salt Injection CYHB2601560Supplement2026/08/17Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗
Fluorouracil Injection CYHB2601362Supplement2026/07/16Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

31 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Diazepam InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310218642026/06/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Dobutamine Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202690882026/04/13Generic approved under the new chemical-drug registration classificationCDE ↗
Iohexol InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized国药准字H200840362026/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iohexol InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized国药准字H200840382026/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iohexol InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized国药准字H200840372026/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Dexrazoxane for InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202558752025/11/04Generic approved under the new chemical-drug registration classificationCDE ↗
Flumazenil InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202541672025/05/13Generic approved under the new chemical-drug registration classificationCDE ↗
Flumazenil InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202541682025/05/13Generic approved under the new chemical-drug registration classificationCDE ↗
Phentolamine Mesilate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310205892025/04/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Neostigmine Methylsulfate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202537012025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Neostigmine Methylsulfate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202537002025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Nicorandil for InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202498432024/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Magnesium Sulfate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202472232024/09/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Pentoxifylline InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202441892024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Macitentan TabletsShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202439022024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
Dobutamine Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202343662023/10/24Generic approved under the new chemical-drug registration classificationCDE ↗
Levosimendan InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202341152023/09/05Generic approved under the new chemical-drug registration classificationCDE ↗
Warfarin Sodium TabletsShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202332682023/03/15Generic approved under the new chemical-drug registration classificationCDE ↗
Digoxin InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202332692023/03/15Generic approved under the new chemical-drug registration classificationCDE ↗
Tramadol Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H200237852023/02/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Fluorouracil InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310205932023/01/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Penehyclidine Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202238852022/11/30Generic approved under the new chemical-drug registration classificationCDE ↗
Succinylcholine Chloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310205992022/09/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Fluorouracil InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202170312022/07/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Haloperidol Lactate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310206652022/07/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amiodarone Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202233722022/06/07Generic approved under the new chemical-drug registration classificationCDE ↗
Bromhexine Hydrochloride InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310227032021/09/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Terbutaline Sulfate InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202137222021/09/13Generic approved under the new chemical-drug registration classificationCDE ↗
Metoprolol Tartrate TabletsShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310207832021/06/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Milrinone InjectionShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H202037262020/12/29Generic approved under the new chemical-drug registration classificationCDE ↗
Captopril TabletsShanghai Xudong Haipu Pharmaceutical Co., Ltd.Shanghai Xudong Haipu Pharmaceutical Co., Ltd.国药准字H310205642020/01/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

22 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
氟哌利多 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20240000781A2026/02/14CDE ↗
甲硫酸新斯的明 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20230000442A2024/12/13CDE ↗
己酮可可碱 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20220000799A2024/05/30CDE ↗
左西孟旦 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20210001119A2023/08/29CDE ↗
盐酸多巴酚丁胺 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20210001064A2025/07/09CDE ↗
硫酸特布他林 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190008483A2025/03/15CDE ↗
氢溴酸加兰他敏 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190007696A2024/12/14CDE ↗
尼可地尔 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190007216A2024/06/13CDE ↗
盐酸雷莫司琼 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190005678A—CDE ↗
羟丁酸钠 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190002563A—CDE ↗
塞替派 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190002562A2025/01/17CDE ↗
亚硝酸异戊酯 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190002561A—CDE ↗
盐酸氮芥 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001774A2025/01/17CDE ↗
甲磺酸酚妥拉明 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001773A2025/02/09CDE ↗
门冬氨酸钙 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001633A2024/11/19CDE ↗
氯化琥珀胆碱 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001632A2024/11/19CDE ↗
去乙酰毛花苷 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001496A2024/12/14CDE ↗
华法林钠 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001495A2024/12/14CDE ↗
单硝酸异山梨酯 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190001494A2024/12/14CDE ↗
盐酸戊乙奎醚 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20190000786A2024/05/29CDE ↗
盐酸妥拉唑林 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20170001489I—CDE ↗
米力农 · No verified English nameShanghai Xudong Haipu Pharmaceutical Co., Ltd.Y20170001439A2023/10/19CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Quetiapine Fumarate Tablets JTH2600102Not stated by source2026/05/27Klocke Pharma-Service GmbH; CHEPLAPHARM Arzneimittel GmbH; Shanghai Xudong Haipu Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.